Literature DB >> 23989781

Trial watch: Clinical trial boost for lentiviral gene therapy.

Monica Hoyos Flight.   

Abstract

Mesh:

Year:  2013        PMID: 23989781     DOI: 10.1038/nrd4111

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

Review 1.  Gene therapy to treat cardiac arrhythmias.

Authors:  Rossana Bongianino; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

2.  Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets.

Authors:  Fang Zheng; Yi-Ji Liao; Mu-Yan Cai; Tian-Hao Liu; Shu-Peng Chen; Pei-Hong Wu; Long Wu; Xiu-Wu Bian; Xin-Yuan Guan; Yi-Xin Zeng; Yun-Fei Yuan; Hsiang-Fu Kung; Dan Xie
Journal:  PLoS Genet       Date:  2015-02-18       Impact factor: 5.917

3.  CCR5 Gene Editing of Resting CD4(+) T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice.

Authors:  Guohua Yi; Jang Gi Choi; Preeti Bharaj; Sojan Abraham; Ying Dang; Tal Kafri; Ogechika Alozie; Manjunath N Manjunath; Premlata Shankar
Journal:  Mol Ther Nucleic Acids       Date:  2014-09-30       Impact factor: 10.183

4.  MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma.

Authors:  Xin-Ran Tang; Xin Wen; Qing-Mei He; Ying-Qin Li; Xian-Yue Ren; Xiao-Jing Yang; Jian Zhang; Ya-Qin Wang; Jun Ma; Na Liu
Journal:  Cell Death Dis       Date:  2017-01-19       Impact factor: 8.469

5.  Broadening the versatility of lentiviral vectors as a tool in nucleic acid research via genetic code expansion.

Authors:  Yongxiang Zheng; Fei Yu; Yiming Wu; Longlong Si; Huan Xu; Chuanling Zhang; Qing Xia; Sulong Xiao; Qi Wang; Qiuchen He; Peng Chen; Jiangyun Wang; Kazunari Taira; Lihe Zhang; Demin Zhou
Journal:  Nucleic Acids Res       Date:  2015-03-12       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.